Donald S. Anson

1.2k total citations
40 papers, 926 citations indexed

About

Donald S. Anson is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Donald S. Anson has authored 40 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Physiology and 19 papers in Genetics. Recurrent topics in Donald S. Anson's work include Lysosomal Storage Disorders Research (24 papers), Virus-based gene therapy research (18 papers) and RNA Interference and Gene Delivery (10 papers). Donald S. Anson is often cited by papers focused on Lysosomal Storage Disorders Research (24 papers), Virus-based gene therapy research (18 papers) and RNA Interference and Gene Delivery (10 papers). Donald S. Anson collaborates with scholars based in Australia, United States and Sweden. Donald S. Anson's co-authors include David Parsons, Sharon Byers, John J. Hopwood, Maria Fuller, Chantelle McIntyre, Julie Bielicki, Maria P. Limberis, Rachel Koldej, Karlea L. Kremer and Kylie R. Dunning and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Donald S. Anson

40 papers receiving 897 citations

Peers

Donald S. Anson
Ming Du United States
Laure Bidou France
Tatiana Rokhlina United States
Heather Coker United Kingdom
Benjamin Strobel Germany
Shoso Yamamoto Japan
Sun‐Hee Hwang United States
Michael A. Perricone United States
John J. Moulds United States
Christopher Kitson United States
Ming Du United States
Donald S. Anson
Citations per year, relative to Donald S. Anson Donald S. Anson (= 1×) peers Ming Du

Countries citing papers authored by Donald S. Anson

Since Specialization
Citations

This map shows the geographic impact of Donald S. Anson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald S. Anson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald S. Anson more than expected).

Fields of papers citing papers by Donald S. Anson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald S. Anson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald S. Anson. The network helps show where Donald S. Anson may publish in the future.

Co-authorship network of co-authors of Donald S. Anson

This figure shows the co-authorship network connecting the top 25 collaborators of Donald S. Anson. A scholar is included among the top collaborators of Donald S. Anson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald S. Anson. Donald S. Anson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derrick‐Roberts, Ainslie L.K., Carmen E. Pyragius, Xenia Kaidonis, et al.. (2014). Lentiviral-Mediated Gene Therapy Results in Sustained Expression of β-Glucuronidase for up to 12 Months in the Gus mps/mps and up to 18 Months in the Gus tm(L175F)Sly Mouse Models of Mucopolysaccharidosis Type VII. Human Gene Therapy. 25(9). 798–810. 19 indexed citations
2.
Anson, Donald S., Chantelle McIntyre, & Sharon Byers. (2011). Therapies for Neurological Disease in the Mucopolysaccharidoses. Current Gene Therapy. 11(2). 132–143. 16 indexed citations
3.
Bielicki, Julie, Chantelle McIntyre, & Donald S. Anson. (2010). Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII. Molecular Genetics and Metabolism. 101(4). 370–382. 19 indexed citations
4.
Kaidonis, Xenia, et al.. (2009). Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses. European Journal of Human Genetics. 18(2). 194–199. 38 indexed citations
5.
Byers, Sharon, et al.. (2009). Lentiviral-mediated correction of MPS VI cells and gene transfer to joint tissues. Molecular Genetics and Metabolism. 97(2). 102–108. 18 indexed citations
6.
Kremer, Karlea L., et al.. (2009). Single‐dose lentiviral gene transfer for lifetime airway gene expression. The Journal of Gene Medicine. 11(10). 861–867. 55 indexed citations
7.
Koldej, Rachel & Donald S. Anson. (2009). Refinement of lentiviral vector for improved RNA processing and reduced rates of self inactivation repair. BMC Biotechnology. 9(1). 86–86. 8 indexed citations
8.
Anson, Donald S., Chantelle McIntyre, Belinda J. Thomas, et al.. (2007). Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA.. PubMed. 5(1). 1–1. 31 indexed citations
9.
Anson, Donald S. & Janice M. Fletcher. (2007). Gene therapy for disorders affecting children, progress and potential. Journal of Paediatrics and Child Health. 43(5). 323–330. 1 indexed citations
10.
Anson, Donald S., et al.. (2006). Gene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?. Current Gene Therapy. 6(2). 161–179. 11 indexed citations
11.
Hii, Charles S., Donald S. Anson, Maurizio Costabile, et al.. (2004). Characterization of the MEK5-ERK5 Module in Human Neutrophils and Its Relationship to ERK1/ERK2 in the Chemotactic Response. Journal of Biological Chemistry. 279(48). 49825–49834. 32 indexed citations
12.
13.
Anson, Donald S.. (2003). Retroviral-Mediated Gene Transduction. Humana Press eBooks. 175. 471–494. 2 indexed citations
14.
Yogalingam, Gouri, Allison C. Crawley, John J. Hopwood, & Donald S. Anson. (1999). Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1453(2). 284–296. 11 indexed citations
15.
Anson, Donald S. & Julie Bielicki. (1999). Sulphamidase. The International Journal of Biochemistry & Cell Biology. 31(3-4). 363–367. 8 indexed citations
16.
Yogalingam, Gouri, Vivienne Muller, John J. Hopwood, & Donald S. Anson. (1999). Regulation of N-Acetylgalactosamine 4-Sulfatase Expression in Retrovirus-Transduced Feline Mucopolysaccharidosis Type VI Muscle Cells. DNA and Cell Biology. 18(3). 187–195. 5 indexed citations
17.
Fuller, Maria, John J. Hopwood, & Donald S. Anson. (1998). Receptor mediated binding of two glycosylation forms of N-acetylgalactosamine-4-sulphatase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1406(3). 283–290. 5 indexed citations
18.
Friderici, Karen H., Kevin Cavanagh, Jeffrey R. Leipprandt, et al.. (1995). Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(2-3). 369–373. 18 indexed citations
19.
Fuller, Maria, Ans van der Ploeg, Arnold Reuser, Donald S. Anson, & John J. Hopwood. (1995). Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐Glucosidase. European Journal of Biochemistry. 234(3). 903–909. 37 indexed citations
20.
Anson, Donald S. & Teresa Occhiodoro. (1994). Transcriptional activity of the CD45 gene promoter in retroviral vector constructs. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1219(1). 81–88. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Du Breakdown of academic impact, for papers by Laure Bidou Breakdown of academic impact, for papers by Tatiana Rokhlina Breakdown of academic impact, for papers by Heather Coker Breakdown of academic impact, for papers by Benjamin Strobel Breakdown of academic impact, for papers by Shoso Yamamoto Breakdown of academic impact, for papers by Sun‐Hee Hwang Breakdown of academic impact, for papers by Michael A. Perricone Breakdown of academic impact, for papers by John J. Moulds Breakdown of academic impact, for papers by Christopher Kitson
Rankless by CCL
2026